D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
PetMed Express
PETS
$41.7M
| $640K | ﹤0.01% |
28,093
-73,134
| -72% | -$1.65M |
|
2827
Genco Shipping & Trading
GNK
$1.11B
| $639K | ﹤0.01% |
85,679
-8,574
| -9% | -$70K |
|
2828
Deere & Co
DE
$166B
| $638K | ﹤0.01% |
3,990
-26,566
| -87% | -$4.24M |
|
|
2829
PUT
Pfizer
PFE
$141B
| $637K | ﹤0.01% |
15,810
-35,204
| -69% | -$1.41M |
|
2830
PUT
China Yuchai International
CYD
$1.74B
| $634K | ﹤0.01% |
+40,000
| New | +$645K |
|
2831
Westwood Holdings Group
WHG
$187M
| $634K | ﹤0.01% |
17,973
+785
| +5% | +$29.4K |
|
2832
Axcelis
ACLS
$3.83B
| $633K | ﹤0.01% |
+31,452
| New | +$639K |
|
|
ANSS
2833
DELISTED
Ansys
ANSS
| $630K | ﹤0.01% |
3,446
-57,634
| -94% | -$9.75M |
|
2834
MGE Energy Inc
MGEE
$3.08B
| $629K | ﹤0.01% |
9,258
-17,086
| -65% | -$1.09M |
|
2835
Oxford Square Capital
OXSQ
$155M
| $629K | ﹤0.01% |
96,711
-2,902
| -3% | -$19.1K |
|
|
RAVN
2836
DELISTED
Raven Industries Inc
RAVN
| $628K | ﹤0.01% |
16,377
-8,613
| -34% | -$327K |
|
|
TLRD
2837
PUT
DELISTED
Tailored Brands, Inc.
TLRD
| $627K | ﹤0.01% |
+80,000
| New | +$947K |
|
2838
BOK Financial
BOKF
$8.58B
| $624K | ﹤0.01% |
7,656
-18,453
| -71% | -$1.55M |
|
2839
Banc of California
BANC
$3.22B
| $623K | ﹤0.01% |
+45,014
| New | +$672K |
|
2840
Spectrum Brands
SPB
$2.04B
| $622K | ﹤0.01% |
11,360
-443
| -4% | -$23.7K |
|
|
AGFS
2841
DELISTED
AgroFresh Solutions Inc
AGFS
| $620K | ﹤0.01% |
185,575
+57,439
| +45% | +$227K |
|
2842
CALL
Interactive Brokers
IBKR
$40.2B
| $619K | ﹤0.01% |
+47,600
| New | +$626K |
|
2843
Beazer Homes USA
BZH
$910M
| $617K | ﹤0.01% |
53,626
-54,443
| -50% | -$651K |
|
2844
CryoPort
CYRX
$754M
| $616K | ﹤0.01% |
+47,646
| New | +$518K |
|
|
JAG
2845
DELISTED
Jagged Peak Energy Inc.
JAG
| $614K | ﹤0.01% |
+58,686
| New | +$606K |
|
|
IVAC
2846
DELISTED
Intevac Inc
IVAC
| $612K | ﹤0.01% |
99,814
+61,172
| +158% | +$352K |
|
2847
CALL
MGM Resorts International
MGM
$11.8B
| $611K | ﹤0.01% |
+23,800
| New | +$653K |
|
2848
PUT
ArcelorMittal
MT
$50.2B
| $611K | ﹤0.01% |
30,000
+2,700
| +10% | +$59.8K |
|
|
ARC
2849
DELISTED
ARC Document Solutions, Inc.
ARC
| $611K | ﹤0.01% |
273,919
-1,200,666
| -81% | -$2.93M |
|
|
CS
2850
PUT
DELISTED
Credit Suisse Group
CS
| $607K | ﹤0.01% |
52,100
+2,100
| +4% | +$25.1K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.